Register for this webinar before July 10!

Webinar: Understanding and Navigating Long-Acting (injectable) HIV Treatment and Prevention Options in BC

Join Health Initiative for Men (HIM) , PAN and Ribbon Community for an overview of a new innovation in HIV treatment and prevention options. Health Canada has approved long-acting options for HIV treatment and prevention, and this is an opportunity to discuss exciting changes in how we can treat and prevent HIV.

Long-acting PrEP, called Apretude, is approved by Health Canada. However, it is not yet available through provincial or federal plans.

Two long-acting HIV treatments are approved by Health Canada and provided by the BC Centre for Excellence under specific circumstances on a case-by-case basis: Cabenuva and Sunlenca.

This webinar will empower frontline staff, educators, and community members with new information on long-acting HIV treatment and prevention options and highlight current realities for accessing long-acting medications in BC.

Wednesday July 10th, 2024

10 – 11:30 AM Pacific time

This webinar is scheduled for 90 minutes. Information on presenters to follow. We look forward to seeing you!


This webinar will support the work of:

  • frontline service providers
  • community educators
  • community advocates
  • people interested in HIV treatment and advocacy


Please note: As this webinar is being presented in partnership with Health Initiative for Men (HIM) and Ribbon Community, your registration information may be shared with these organizations.

 Register for this webinar before July 10!